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Presenilin 1 (PSEN1)mutations cause autosomal dominant familial Alzheimer’s disease (FAD). PSEN1mutation
carriers undergo the course of cognitive deterioration, which is typical for sporadic Alzheimer’s disease but
disease onset is earlier and disease progression is faster. Here, we sought to detect signs of FAD in presympto-
matic carriers of the PSEN1 mutation (C410Y) by use of a neuropsychological examination, functional MRI
during learning and memory tasks and MRI volumetry. We examined five non-demented members of a FAD
family and 21 non-related controls. Two of the five family members were carrying the mutation; one was
20 years old and the other 45 years old. The age of clinical manifestation of FAD in the family studied here is
48 years. Neuropsychological assessments suggested subtle problems with episodic memory in the 20-year-
old mutation carrier. The middle-aged mutation carrier fulfilled criteria for amnestic mild cognitive impair-
ment. The 20-year-old mutation carrier exhibited increased, while the middle-aged mutation carrier exhibited
decreased brain activity compared to controls withinmemory-related neural networks during episodic learning
and retrieval, but not during a working-memory task. The increasedmemory-related brain activity in the young
mutation carriermight reflect a compensatory effort to overcome preclinical neural dysfunction caused by first
pathological changes. The activity reductions in the middle-aged mutation carrier might reflect gross neural
dysfunction in a more advanced stage of neuropathology. These data suggest that functional neuroimaging
along with tasks that challenge specifically those brain areas which are initial targets of Alzheimer’s disease
pathology may reveal activity alterations on a single-subject level decades before the clinical manifestation of
Alzheimer’s disease.
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Introduction
The first clinical signs of Alzheimer’s disease are usually
difficulties with episodic memory. Episodic memory is
critically dependent on the intact functioning of the medial
temporal lobe (MTL) (Rempel-Clower et al., 1996; Vargha-
Khadem et al., 1997). The MTL is the brain area initially
affected by intracellular neurofibrillary tangle formation in
the course of Alzheimer’s disease (Braak and Braak, 1996).
Neurofibrillary tangle formation spreads from the MTL to
the temporal neocortex and on to regions of the parietal,
frontal and finally the occipital lobes during the course of
Alzheimer’s disease. Extracellular amyloid beta 42, on the
other hand, is broadly and diffusely deposited within cortex
with no clear neuroanatomical pattern of progression (Price
et al., 1991; Braak and Braak, 1996; Delacourte et al., 1999).
Compared to the common sporadic forms of Alzheimer’s
disease (SAD), the less frequent forms of familial
Alzheimer’s disease (FAD) are associated with a younger
age of first clinical symptoms, a faster disease progression
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and more abundant tissue histopathology (Gomez-Isla et al.,
1997; Lippa et al., 2000; Sakamoto et al., 2002). FAD is a
fully-penetrant autosomal dominant trait. It has been
associated with mutations in the amyloid precursor protein
gene on chromosome 21 (Goate et al., 1991), the presenilin 1
(PSEN1) gene on chromosome 14 (Alzheimer’s Disease
Collaborative Group, 1995; Sherrington et al., 1995) and the
presenilin 2 gene on chromosome 1 (Levy-Lahad et al., 1995;
Rogaev et al., 1995). The presenilins play not only essential
roles in the neural development by acting on the notch
signalling pathway, but also in synaptic plasticity, long-term
memory and neuronal survival (for reviews see Czech et al.,
2000; Wines-Samuelson and Shen, 2005). Of all FAD
cases 55% are caused by mutations in PSEN1 (Cruts
and van Broeckhoven, 1998). To date, >128 mutations in
PSEN1 have been detected (http://molgen-www.uia.ac.be/
ADMutations), with the majority of them being missense
mutations that give rise to a single amino acid substitution.
These mutations are associated with ages of Alzheimer’s
disease diagnosis ranging from 25 to 64 years (Tandon et al.,
2000; Rogaeva, 2002). On the cellular level, pathogenic
PSEN1 mutations modify amyloid precursor protein
processing, thereby leading to an enhanced amyloid beta
42 secretion (Scheuner et al., 1996). Alzheimer’s disease
patients carrying PSEN1 mutations exhibit significant
increases in plasma amyloid beta 42 levels and massive
deposition of amyloid beta 42 in the brain (Lemere et al.,
1996; Iwatsubo, 1998), which precede overt neuronal loss
(Lippa et al., 1998). A role of PSEN1 mutations in tau
pathology has also been suggested by the finding of
tau hyperphosphorylation in PSEN1 transgenic mice
(Boutajangout, 2002).
To our knowledge, there are no neuroimaging studies in
the literature on the effects of PSEN1 mutations on brain
activity in young mutation carriers. Examinations with
fluorodeoxyglucose positron emission tomography (PET) in
cognitively intact carriers of the apolipoprotein E «4 allele
(APOE4), the major genetic risk factor for sporadic
Alzheimer’s disease (SAD; Small et al., 2000; de Leon et al.,
2001; Reiman et al., 2004), revealed a reduced glucose
metabolism in the resting state. These cognitively intact
subjects exhibited abnormally low rates of glucose metabo-
lism in the same brain regions as patients with probable
Alzheimer’s disease, namely the posterior cingulate gyrus,
parietal, temporal and prefrontal regions.
We hypothesize that a handicapped system—in the case of
Alzheimer’s disease the MTL memory system—should reveal
its dysfunction more readily under challenge than at rest. In
this study, we therefore challenged the hippocampus and the
rhinal cortex, areas initially affected by neurofibrillary tangle
formation, by memory tasks tailored to the computational
functions of these regions in order to uncover earliest
functional alterations in presymptomatic PSEN1 mutation
carriers. In this vein, Bookheimer et al. (2000) and Bondi
et al. (2005) found a greater magnitude and extent of brain
activity in elderly, but cognitively intact APOE4 carriers
compared to non-carriers during memory-activation
tasks. These authors suggested that APOE4 carriers had
increased their memory-related brain activity in an effort to
compensate for preclinical dysfunction caused by neuro-
pathology. Here we explore whether such memory-related,
compensatory activity increases might be found even in
young subjects at risk for Alzheimer’s disease and on a
single-subject level instead of group statistics. Young carriers
of a gene mutation associated with FAD are ideal candidates
to investigate these questions because their risk of
developing FAD is 100%. Because neurofibrillary tangle
formation within the MTL can be found as early as 30 years
prior to the diagnosis of SAD (Price et al., 1991; Ohm et al.,
1995; Braak and Braak, 1996; Ghebremedhin et al., 1998;
Delacourte et al., 1999), we assume that tangle formation
would also occur early in FAD and that it might reflect in
subtle functional disturbances that can be picked up with
functional imaging.
Here, we report a family with FAD caused by the
published PSEN1 C410Y mutation (Campion et al., 1995).
Memory-related brain activity was measured in five non-
demented members of this family and in 21 healthy non-
related controls using functional MRI (fMRI). We sought to
detect functional changes related to memory formation and
retrieval in a mutation carrier several decades before the
clinical manifestation of Alzheimer’s disease, which is 48
years in this family. Two of the five family members were
carrying the PSEN1 mutation, a 20-year-old and a 45-year-
old. On grounds of the ‘compensatory hypothesis’ (Book-
heimer et al., 2000; Bondi et al., 2005), we anticipated
enhanced brain activity during learning and memory in the
20-year-old mutation carrier compared with non-carrying
relatives and controls. Because reductions in hippocampal,
entorhinal and perirhinal volumes have been found years
before the clinical manifestation of Alzheimer’s disease (Fox
et al., 1996a, b; Kaye et al., 1997; Reiman et al., 1998), we
also examined the brain morphological variability in our
subjects. We measured the volumes of the hippocampus,
parahippocampal gyrus, total grey and total white matter.
Moreover, all members of our FAD family underwent an




The five members of our FAD family were three young and two
middle-aged individuals. Of these, a 20-year-old and a 45-year-old
subject carried the PSEN1 C410Y mutation first described by
Campion et al. (1995). To conceal the identity of the family
members, the family pedigree, the familial degrees of relationship,
and the subjects’ gender are not reported. The control group
consisted of 21 healthy subjects who were matched to the three
young family members’ ages, years of education and APOE
genotypes (see Table 1). All controls and family members denied
any past or current psychiatric and neurological conditions and the
consumption of illegal drugs. Their anatomical T1-weighted MRI
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scans showed normal brain morphology. All subjects gave written
informed consent to participate in the study after the nature and
possible consequences of the study had been explained. None of
the family members wished to be informed of their genetic status
after genetic counselling. The experimenters were blind to the
genotype of the subjects during data collection. The study was
approved by the local Ethics Committee.
Genotyping
Genomic DNA was extracted from whole blood. Mutation
screening was performed by direct sequencing of both strands of
the PCR-amplified coding exons of PSEN1 (exons 2–12), presenilin
2 (exons 3–12), and amyloid precursor protein (exons 16 and 17).
Amplification was done by a universal ‘touch down’ protocol, using
primers as described earlier (Finckh et al., 2000). Purified PCR
products were sequenced by cycle sequencing using fluorescent dye
dideoxy terminators (ABI PRISM BigDye(tm) Terminators v 3.0
Cycle Sequencing Kit) and analysis was performed on an ABI
PRISM 310 Genetic Analyzer. APOE genotypes were assessed
using the LightCycler instrument (Roche Diagnostics Corpora-
tion) (Bernard et al., 1999).
Functional MRI procedure
All subjects underwent two fMRI experiments, one on episodic
memory and the other on working memory, as well as structural
MRI and a neuropsychological examination. Trials in the fMRI
experiments were blocked. The same stimuli were used for all
subjects to avoid stimulus-generated variance. The sequence of
condition blocks within fMRI time-series was counterbalanced
across subjects. Instruction slides announced each task block to
subjects. Responses were collected with a response box that subjects
held in their dominant hand. Subjects practised all fMRI tasks prior
to scanning (with different stimuli) until they felt comfortable with
tasks.
Encoding
We presented 16 face–profession pairs in the associative learning
condition, 16 faces in the single face learning condition and 24
head contours (without physiognomy) in the visual baseline
condition of a first encoding run which constituted one fMRI time-
series. This fMRI time-series (Fig. 1) was repeated twice adding to
three encoding runs or three fMRI time-series. The repetition of
learning runs had the purpose to allow for a progressively deeper
encoding of the learning material. For associative learning of the
face–profession pairs, subjects were instructed to imagine each
presented person acting in a scene of the written profession and to
indicate by button press whether it was easy or hard to imagine
a scene. This imagination task automatically induces the establish-
ment of semantic person-occupation associations and activates
the hippocampus and associated cortices (Degonda et al., 2005).
Importantly, subjects were requested to imagine the same scene for
a given face–profession pair during encoding Runs 2 and 3 as
during encoding Run 1. This adds the retrieval of the scenes
imagined in previous runs to the encoding processes in Runs 2 and
3. The instruction for the learning of single faces was to decide
whether a face was pleasant or unpleasant. This instruction induces
a deep (semantic) encoding of the presented faces. The instruction
given for the visual baseline task was to indicate by button press
whether the area of the left or right ear of a head contour was
larger. Learning conditions consisted of four 24 s blocks with four
trials of 6 s per block. The visual baseline condition consisted also
of four 24 s blocks, with six trials of 4 s per block.
Retrieval
There was a single fMRI time-series for retrieval, which included
the associative retrieval condition (face–profession associations),
the face recognition condition (studied faces), a novel faces
detection condition (unstudied faces) and the same visual baseline
condition that had been included in the encoding time-series.
For associative retrieval, the previously presented faces were given
as cues. Subjects were instructed to remember the associated
occupation and to indicate its superordinate category (academic
versus workman) by button press. For face recognition/novel face
detection, studied and unstudied faces were presented in separate
blocks with the request to indicate by button press whether a
face was remembered (recollection; episodic memory) or known
(familiarity; semantic memory) or judged new (Tulving, 1985;
Gardiner, 1988). Retrieval conditions consisted of four 24s blocks
with four trials of 6 s per block. The visual baseline condition
consisted also of four 24 s blocks with six trials of 4 s per block.
Working memory
There was a single fMRI time-series with a 2-back task assessing
working memory and a baseline task (‘x-target’ task) measuring
concentration. The 2-back task required subjects to respond to a
letter repeat with one intervening letter (e.g. S – f – s – g . . .). The
‘x-target’ task required subjects to respond to the occurrence of
the letter ‘x’ in a sequence of letters (e.g. N – l – X – g . . .). We
presented 50 upper- or lowercase letters typed in black on white
background. There were five blocks of 26 s per condition. Each
block comprised 13 upper- or lowercase letters, which were
presented for 2 s each.
Table 1 Demographics
Y1 C410Y Y2 Y3 M1 C410Y M2 Controls (n = 21)
Age 20 20 23 45 52 22.2 6 1.75*
HAWIE-R total IQ 133 131 102 111 101 122.5 6 10.18*
HAWIE-R performance IQ 134 116 108 100 110 119.7 6 11.78*
HAWIE-R verbal IQ 126 136 96 118 94 121.1 6 10.35*
Handedness R R R R L R (n = 19), L (n = 2)
Years of education 13 12 15 13 9 14.13 6 1.39*
APOE «2/«3 «2/«3 «2/«4 «2/«3 «2/«3 «2/«3 (n = 11), «3/«3 (n = 10)
Y, young; M, middle-aged; C410Y, mutation in the PSEN1 gene; APOE, apolipoprotein E; R, right; L, left.
*Means 6 SD.
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MRI data acquisition
MR measurements were performed on a 3T Philips Intera
whole body MR scanner equipped with an eight-channel Philips
SENSE head coil. Functional data were obtained from 32
transverse slices parallel to the AC–PC plane covering the whole
brain with a measured spatial resolution of 2.8 · 2.8 · 4 mm3
(acquisition matrix 80 · 80) and a reconstructed resolution of 1.7 ·
1.7 · 4 mm3. Data were acquired using a parallel imaging
technique, SENSE-sshEPI, with an acceleration factor of R = 2.0.
Other scan parameters were TE = 35 ms, TR = 3000 ms,  = 82.
We have previously tested this protocol against other SENSE
protocols and against coventional ssh-EPI on this 3T Philips
scanner (Schmidt et al., 2005) with the associative learning task
used in the present study. This protocol provided excellent
image quality particularly in the MTL, but also in neocortex, by
markedly reducing susceptibility related distortions and saving
signal that can be compared across conditions (for raw images and
SNR in MTL and neocortex using this protocol see Schmidt et al.,
2005).
A standard 3D T1-weighted scan was obtained for anatomical
reference with a measured spatial resolution of 1 · 1 · 1.5 mm3
(acquisition matrix 224 · 224), a reconstructed resolution of
0.9 · 0.9 · 0.8 mm3, TE = 2.3 ms, TR = 20 ms and  = 20, no
interslice gaps. A 2D T1-weighted inversion-recovery anatomical
scan, oriented perpendicularly to the long axis of the hippocampus,
was obtained for hippocampal and parahippocampal volumetry
over 33–39 slices with a measured spatial resolution of 0.5 · 0.6 ·
1.5 mm3 (acquisition matrix 400 · 320) and a reconstructed spatial
resolution of 0.4 · 0.4 · 1.5 mm3, TE = 15 ms, TR = 4200 ms,
 = 20, IR delay 400 ms, no interslice gaps.
Analysis of fMRI data
Image pre- and post-processing and the statistical analyses were
performed with SPM2 (http://www.fil.ion.ucl.ac.uk/spm) using
standard preprocessing procedures (Friston et al., 1995a).
For the whole-brain SPM analyses, data were realigned, spatially
normalized and spatially smoothed to a full width of 8 mm at half-
maximal resolution using a Gaussian filter.
Fig. 1 FMRI tasks. The left side shows example stimuli used for associative learning, single face learning and the visual baseline condition.
The right side shows example stimuli used for associative retrieval, face recognition, novel face detection, and the visual baseline condition.
Alex Kayser granted us permission to use and reproduce faces from his book ‘Heads’, 1985, New York: Abbeville Press.
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For the region-of-interest (ROI) analyses within the subjects’
native brain spaces, data were realigned and smoothed to a full
width of only 4 mm at half-maximal resolution and no spatial
normalization was performed
At the single-subject level, data were analysed according to the
fixed effects model of SPM2. The six head movement parameters
were included in the model as confounding factors. Data were
high-pass filtered with a filter-value tailored to each fMRI time-
series according to 2 · SOA (stimulus onset asynchrony) · TR
(repetition time). Contrasts were computed for each subject
comparing the learning (Run 1), the retrieval and the novelty
detection conditions to the visual baseline condition and the 2-back
task to the x-target task. At the second level, within-subject
contrasts were entered into random effects analyses (Two sample
t-tests, SPM2; Friston et al., 1995b). Each family member was
compared to the control group. SPM takes the control group’s
variance as an estimate for the single subject’s variance when
calculating two sample t-tests with only one subject in a group. To
determine whether the family members’ activity alterations might
be attributable to normal inter-subject variability, we randomly
selected five young control subjects (R1, R2, R3, R4 and R5) from
our control group of 21 subjects and compared their associative
learning and associative retrieval contrasts (each versus visual
baseline) to the contrasts of the remaining 20 controls. Height
thresholds were set at P = 0.001 (uncorrected for multiple com-
parisons) and extent thresholds were 15 voxels in neocortex and
1 voxel in hippocampus and rhinal cortex. If activity differences in
the hippocampus and rhinal cortex reached significance only at the
more liberal height threshold of P = 0.005, these results are also
indicated in the results tables and marked as such.
The ROI analyses were performed in native space for the
hippocampus using the MarsBar toolbox for SPM2 (Brett et al.,
2002). Each subject’s hippocampi were manually delineated on the
anatomical 3D-T1-weighted coronal MRI slices and divided into an
anterior, a middle and a posterior section. Mean contrast values per
subject and condition (versus the visual baseline task) were
extracted for each ROI. The mean contrast values of each family
member and of each of the five randomly selected controls
(from the larger control group) were then compared with the 7th
(P7) and 93rd (P93) percentile of the control group’s mean
contrast values.
MRI volumetry
Volumes of the total grey and white matter were computed with
SPM2 on the 3D-T1-weighted structural whole-brain MRI scans.
Images were normalized into the MNI T1 template by use of the
standard bounding box. Next, they were segmented into grey
matter, white matter and CSF. The multiplication of the
standardized grey and white matter volumes by the determinant
of the linear transformation matrix yielded grey and white matter
volumes in cm3. In addition, two independent raters manually
delineated the hippocampal formation (CA regions, dentate gyrus
and subiculum, excluding the fimbria) and the parahippocampal
gyrus (Henke et al., 1999) on the 2D-T1-weighted high-resolution
structural MRI scans using the software Pmod (http://www.pmod.
com). The parahippocampal gyrus was delineated over a length that
corresponded to the length of the hippocampus. Raters relied on
descriptions of anatomical landmarks and subdivisions of the MTL
as described by Insausti et al. (1998) and Duvernoy (1998). Inter-
rater reliabilities ranged between r = 0.8 and 0.98. Each family
member’s volumes were compared with the 7th (P7) and 93rd
(P93) percentile of the control group’s volumes. Male subjects were
compared with a male control group (n = 9; age: mean = 21.1,
SD = 1.7), female subjects with a female control group (n = 13; age:
mean = 22, SD = 1.8).
Neuropsychology
Family members and controls (controls: n = 20, because one
control subject was not available for neuropsychological testing)
underwent a comprehensive neuropsychological examination.
Memory functions were assessed with the Wechsler Memory
Scale—Revised (WMS-R), intelligence with the Hamburg Wechsler
Intelligence Scale Revised (HAWIE-R), spatial cognition with the
Luria Mental Rotation Test, fluency with a verbal (S-words) and a
non-verbal (5-point) production task, concept finding/switching
with the Kramer Card Sorting Test, and the control of interference
with the Stroop test. The two middle-aged family members took
also the CERAD-NAB test, which includes the Mini-Mental State
Examination (MMSE). Scores obtained by each family member
were compared with the 7th (P7) and 93rd (P93) percentile of the
control group’s scores and with the normative values provided by




Y1 C410Y (Y1, young no. 1, carrying the C410Y mutation)
was 20 years old at the time of this examination. This subject
fell below the young control group’s 7th percentile in the
WMS-R indices for visual memory and delayed memory but
was within mean (M) 6 1 SD of the age-matched test norms
(Fig. 2, Supplementary Table S1). It was the performance in
Fig. 2 Neuropsychology. The figure shows the performance scores
of the five family members in the indices of the WMS-R and the
HAWIE-R. Family members are represented by colours (see
legend). The grey area spans the control group’s performance
range between the 7th and the 93rd percentile. IQ, intelligence
quotient; MQ, memory quotient.
2912 Brain (2006), 129, 2908–2922 C. R. A. Mondadori et al.
the visual paired associates (VPA) immediate cued recall
(VPA1) and the delayed cued recall (VPA2) subtests that
lowered these two indices. VPA1 and VPA2 fell below the
young control group’s M  2 SD (VPA1: Y1 C410Y = 10,
controls M = 17.4, SD = 0.88; VPA2: Y1 C410Y = 4, controls
M = 5.95, SD = 0.22), but just within M 6 1.5 SD of the age-
matched test norms (VPA1: Y1 C410Y = 10, norm group
M = 14.1, SD = 3.14; VPA2: Y1 C410Y = 4, norm group
M = 5.48, SD = 0.87). Y1 C410Y performed within the
young control group’s P7/P93 range with respect to all other
neuropsychological variables (Supplementary Table S1).
Subject Y2 (Y2, young no. 2, no mutation carrier) was
20 years old at the time of this examination. Y2 performed
within the young control group’s P7/P93 range of scores
in all neuropsychological tasks (Fig. 2, Supplementary
Table S1).
Subject Y3 (Y3, young no. 3, no mutation carrier) was
23 years old at the time of this examination. Y3 exhibited
rather weak cognitive abilities across cognitive domains
relative to the other young family members. The WMS-R
indices for verbal memory, visual memory, general memory
and delayed memory as well as the total IQ score and the
verbal IQ score were ranging below the 7th percentile of the
young control group, but were within M 6 1 SD of age-
matched test norms (Fig. 2, Supplementary Table S1).
Middle-aged family members
M1 C410Y (M1, middle-aged no. 1, carrying the C410Y
mutation) was 45 years old at the time of this examination.
This subject fell below the young control group’s 7th
percentile in all WMS-R memory indices (Fig. 2). The
WMS-R delayed memory index and the MMSE score
also ranged below M  1.5 SD of the age-matched test
norms. General intelligence, spatial cognition, and executive
functions were within norms and even within the young
control group’s P7/P93 range (Fig. 2, Supplementary
Table S1). M1 C410Y’s cognitive profile therefore fulfilled
the criteria for amnestic mild cognitive impairment by
Petersen et al. (2001).
Subject M2 (M2, middle-aged no. 2, no mutation carrier)
was 52 years old at the time of this examination. The total
IQ index and the verbal IQ index fell below the young
control group’s P7/P93 range (Fig. 2, Supplementary
Table S1), but were within M 6 1 SD of the age-matched
test norms. All other performance measures were within
M 6 1.5 SD of the age-matched test norms.
Behavioural performance in fMRI
experiments
Young family members
The three young family members performed within the
young control group’s P7/P93 performance range in all
behavioural measures collected during the fMRI experiments
(Table 2).
Middle-aged family members
Both middle-aged family members fell below the young
control group’s P7/P93 range with their remember (Tulving,
1985; Gardiner, 1988) and new answers to single faces
(Table 2). Notably, the middle-aged mutation carrier M1
C410Y yielded the smallest number of correct remember and
know (Tulving, 1985; Gardiner, 1988) answers to faces
compared with the young control group and with the other
Table 2 Performance fMRI tasks
Y1 C410Y Y2 Y3 M1 C410Y M2 Controls
(M 6 SD) (P7/P93)
Associative learning
No. easy (run 1) 9 9 9 9 11 8.76 6 2.28 5/12.46
No. easy (run 2) 10 12 9 9 10 9.57 6 2.64 4.54/13.46
No. easy (run 3) 13 10 10 7 10 10.67 6 2.35 6.62/14.46
No. easy (runs 1–3) 1 4 1 2 1 1.9 6 2.07 5.92/1
Single face learning
No. pleasant (run 1) 8 8 5 7 6 7 6 2.21 3.08/11
No. pleasant (run 2) 8 8 4 8 6 7 6 2.72 2.08/12
No. pleasant (run 3) 9 9 5 9 7 7.29 6 2.49 2.62/11.46
No. pleasant (runs 1–3) 1 1 0 2 1 0.29 6 1.49 3/2
Associative retrieval
No. correct 11 11 9 11 11 11.9 6 2.2 7.54/14.46
Face recognition
No. correct remember (hits - false alarms) 14 11 7 2 2 10.25 6 3.75 3.41/15.53
No. correct know (hits - false alarms) 1 3 5 1 6 2.95 6 3.55 1.06/10.53
Novel face detection
No. correct new (correct rejections – misses) 15 14 12 4 9 13.29 6 2.19 9.54/16
Working memory
2-back No. correct (hits - false alarms) 11 10 10 8 3 8.85 6 2.89 3.47/12
Attention
x-target No. correct (hits - false alarms) 13 13 13 13 12 12.95 6 0.22 12.47/13
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family members (S remember and know; Y1 C410Y : 15, Y2:
14, Y3: 12, M1 C410Y : 3, M2: 8, Table 2). M2 appeared to
compensate the low number of correct remember answers
(reflecting episodic memory) with a larger number of correct
know answers (reflecting semantic memory). On the other
hand, the two middle-aged family members’ numbers of
correctly recalled face–profession associations were within
the P7/P93 performance range of the young control group
(Table 2). M2 exhibited difficulties with the 2-back task
relative to the other family members and scored below the
P7/P93 performance range of the young control group.
Functional imaging results
The full results of SPM contrasts between each family
member and the controls are given in Supplementary




Y1 C410Y showed enhanced brain activity during learning,
retrieval, and novelty detection relative to the young controls
(Supplementary Table S2), while the young controls did
not exhibit a single spot of activity enhancement over
Y1 C410Y. Almost all of Y1 C410Y’s activity enhancements
were situated in left frontal, left temporal, and left parietal
neocortices, and the left hippocampus (Tables 3
and 4, Supplementary Table S2, Fig. 3). To determine
whether Y1 C410Y’s activity enhancements might be
attributable to causes of inter-subject variability other than
the mutation, we randomly selected five young control
subjects (R1, R2, R3, R4 and R5) and compared their
associative learning and associative retrieval contrasts (each
versus visual baseline) to the contrasts of the remaining 20
controls. There were only minor deviations of activity levels
in the selected subjects. R4 (retrieval) and R5 (learning)
showed some left frontal activity enhancements, but these
were discrete relative to Y1 C410Y’s general activity
overshoot (Fig. 4). R1, R2, and R3 did not show any
activity deviations. The ROI analysis confirmed Y1 C410Y’s
activity enhancement within the left hippocampus during
associative learning: Y1 C410Y’s activity in the middle
portion of the left hippocampus exceeded the 93rd
percentile of the young controls’ activity (Supplementary
Table S7). For single face learning, both retrieval conditions,
and novelty detection, Y1 C410Y’s hippocampal activity was
well within the controls’ P7/P93 limits.
Y2 exhibited learning-, retrieval- and novelty-related
activity levels comparable to those in the young controls.
There were very few areas of activity differences, which
went in both directions, Y2 over the controls and the
controls over Y2 (Tables 3 and 4, Supplementary Table S3).
Bidirectional activity differences were also found in the ROI
analysis: Y2 showed left anterior hippocampal activity that
exceeded the controls’ P93 during face recognition and left
posterior hippocampal activity that fell below the controls’
P7 during associative retrieval (Supplementary Table S7).
Y3 showed a few learning-, retrieval- and novelty-related
activity increases mainly in the fusiform gyrus relative
to controls (Tables 3 and 4, Supplementary Table S4).
The controls, on the other hand, exhibited activity increases
relative to Y3 in the parahippocampal gyrus, rhinal cortex,
medial frontal gyrus, superior temporal gyrus and retro-
splenial cortex during associative retrieval, face recognition
and novel face detection. A rather weak MTL activity in
Y3 became again apparent in the ROI analysis: Y3’s
mean activity fell below the controls’ P7 within many
segments of the left hippocampus for single face learning,
associative retrieval, and face recognition, and within
the right anterior hippocampus for face recognition
(Supplementary Table S7).
Middle-aged family members
M1 C410Y exhibited virtually no brain area where task-
related activity exceeded activity levels of the young controls
(Tables 3 and 4, Fig. 3, Supplementary Table S5). But
the young controls exhibited increased activity levels
compared to M1 C410Y throughout the MTL, the prefrontal
cortex and superior temporal gyrus during learning, retrieval
and novelty detection. These activity differences were
most pronounced during associative learning and retrieval
(Tables 3 and 4). The hippocampal ROI analysis confirmed
these results: M1 C410Y’s activity levels were generally low
and fell below the control group’s 7th percentile in many left
and right hippocampal segments for associative learning and
retrieval, single face learning, face recognition and novel face
detection (Supplementary Table S7).
M2 also exhibited reduced task-related brain activity
levels relative to the young controls, but these were restricted
to fewer brain areas than M1 C410Y’s. M2’s weak activity
levels (relative to the young controls’) were focused on the
MTL; some areas of weak activity were also found in
prefrontal, temporal and parietal areas. These weak (relative
to the controls’) task-related activity increases appeared
chiefly during associative learning and associative retrieval
(Tables 3 and 4) (Supplementary Table S6). The ROI
analysis indicated that M2’s left posterior hippocampal
activity was consistently ranging below the controls’ P7
during all tasks (Supplementary Table S7).
Working memory
All family members
The family members showed good working memory and
concentration skills, except for M2 who performed <M 2
SD in the 2-back task relative to the young controls. All
family members exhibited brain activity enhancements
relative to the young controls in the 2-back task (versus
the x-target task) within prefrontal, parietal, temporal and
cerebellar areas (Supplementary Tables S2–S6).
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MRI volumetry results
The manual measurements of the hippocampus and para-
hippocampal gyrus revealed comparable volumes between
the family members and their sex-matched control groups
(data not shown in order to conceal the subjects’ gender
which is reflected in the sizes). Automated whole-brain
grey and white matter segmentation showed smaller total
grey matter volumes in subjects Y1 C410Y and Y3 (below
the control group’s 7th percentile) but just sufficient
white matter volumes in both subjects. The head transfor-
mation matrices of Y1 C410Y and Y3, which resulted
from the spatial normalization in SPM2, suggest that the
small grey matter values were probably due to small head
sizes.
Table 3 Brain activation differences between each family member and the control group during associative learning
Brain region Left/right MNI coordinates (mm)
x y z BA kE t
Two sample t-test
Associative learning versus visual baseline
Y1 C410Y > controls
Hippocampus L 38 34 6 7 3.44*
Fusiform gyrus L 22 78 18 19 147 7.31
Fusiform gyrus L 34 46 22 37 210 6.02
Superior frontal gyrus L 12 30 58 8 20 6.3
Middle frontal gyrus L 50 16 42 8 112 5.92
Middle frontal gyrus L 34 56 4 10 61 5.02
Middle frontal gyrus L 30 42 16 46 47 4.68
Middle temporal gyrus L 60 58 16 37 210 5.78
Supramarginal gyrus L 38 60 38 40 57 4.44
Precuneus L 6 60 44 7 265 5.98
Y2 > controls
Superior temporal gyrus R 52 16 12 38 20 3.8
Insula R 40 14 2 16 4.12
Y3 > controls
Fusiform gyrus R 40 50 20 37 19 4.69
Fusiform gyrus L 46 48 30 37 19 4.66
M1 C410Y > controls
No significant differences
M2 > controls
Superior frontal gyrus L 18 14 60 6 33 4.69
Superior temporal sulcus R 46 28 4 44 5.36
Fusiform gyrus L 20 74 8 19 32 5.43
Associative learning versus visual baseline





Superior temporal gyrus L 58 24 10 22 18 4.13
Controls > M1 C410Y
Hippocampus R 26 10 22 17 4.56
Hippocampus R 26 30 6 5 3.98
Amygdala L 32 8 26 11 4.74
Middle frontal gyrus L 24 60 2 10 72 7.45
Middle frontal gyrus R 24 60 8 10 31 4.92
Superior temporal gyrus L 56 2 4 22 101 6.16
Superior temporal gyrus L 50 20 4 22 92 6.1
Superior temporal gyrus R 52 8 4 22 38 4.29
Cingulate gyrus R 2 38 6 24 35 3.58
Fusiform gyrus L 32 36 30 36 26 4.65
Controls > M2
Hippocampus R 36 28 14 48 5.8
Hippocampus R 22 28 12 5 4.33
Parahippocampal gyrus L 14 44 4 30 624 7.77
Superior temporal sulcus R 44 2 24 23 5.2
t = value of peak within significantly activated cluster of voxels; kE = cluster size (in voxels); BA = Brodmann area; L = left; R = right.
*P < 0.005.
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Discussion
We examined five non-demented members of a family with
FAD due to the PSEN1 C410Y mutation (Campion et al.,
1995). The age of clinical manifestation of Alzheimer’s
disease in this family is 48 years. Our aim was to uncover
possible preclinical abnormalities in cognitive functions,
memory-related brain activity and brain volumes in those
family members who carry the mutation. Of the five family
members, a 20-year-old and a 45-year-old subject carried the
mutation.
The 20-year-old mutation carrier’s cognitive performance
in the neuropsychological assessment was normal relative to
the published norms of the applied inventories. However,
this subject’s performance in the visual paired-associates
learning and recall test (WMS-R subtests) fell below the
matched controls’ M 2 SD range. Although this mutation
Table 4 Brain activation differences between each family member and the control group during associative retrieval
Brain region Left/right MNI coordinates (mm)
x y z BA kE t
Two sample t-test
Associative retrieval versus visual baseline
Y1 C410Y > controls
Middle frontal gyrus L 38 56 8 10 49 6.08
Middle frontal gyrus R 40 52 10 10 47 5.23
Inferior frontal gyrus L 50 16 42 9 23 3.95
Inferior frontal gyrus L 38 24 2 47 19 4.22
Fusiform gyrus L 22 78 20 19 35 4.41
Supramarginal gyrus R 40 64 40 40 61 6.08
Inferior parietal lobule L 38 46 44 40 36 4.34
Inferior parietal lobule L 38 60 40 40 41 4.24
Supramarginal gyrus R 50 64 32 40 18 3.91
Y2 > controls
Inferior frontal gyrus R 44 34 6 47 44 5.6
Y3 > controls
Fusiform gyrus R 40 52 24 37 76 7.11
Fusiform gyrus R 34 70 20 19 36 4.28
Fusiform gyrus L 44 48 26 37 17 4.72
M1 C410Y > controls
Orbital gyrus R 18 54 10 11 22 6.07
M2 > controls
No significant differences
Associative retrieval versus visual baseline
Controls > Y1 C410Y
No significant differences
Controls > Y2
Superior frontal gyrus L 2 64 16 9 33 4.62
Cingulate gyrus L 8 58 26 31 37 4.6
Cingulate gyrus L 6 46 6 32 43 4.49
Controls > Y3
Parahippocampal gyrus L 12 36 2 15 4.21
Rhinal cortex L 22 6 32 15 5.02
Medial frontal gyrus R 2 58 10 10 15 5.02
Retrosplenial cortex L/R 8 48 10 29 147 5.11
Controls > M1 C410Y
Hippocampus L 22 30 10 10 4.07
Hippocampus R 24 10 20 2 3.68
Parahippocampal gyrus R 30 32 14 6 3.81
Perirhinal cortex L 16 4 32 19 5.43
Superior temporal gyrus L 52 2 6 22 51 5.38
Superior temporal gyrus R 62 8 4 22 18 4.36
Controls > M2
Hippocampus R 34 30 12 95 5.17
Hippocampus L 26 34 8 14 4.24
Middle frontal gyrus L 40 10 54 6 71 4.93
Superior temporal gyrus R 48 10 26 38 74 5.27
Retrosplenial cortex L 6 46 14 29 17 5.03
t = value of peak within significantly activated cluster of voxels; kE = cluster size (in voxels); BA = Brodmann area; L, left; R, right.
*P < 0.005.
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carrier was well within the range of the matched controls
with respect to all other test scores, this subject lost 13 points
from the immediate recall of the Wechsler stories (Logical
Memory I) to the delayed recall (Logical Memory II). The
controls lost between 0 and 8 points (mean 2.4 points).
Moreover, Y1’s performance on the visual paired-associates
learning/recall test and the loss of information in the stories
test appear disproportionately low when Y1’s high IQ scores
(total IQ: 133; performance IQ: 134; verbal IQ: 126) are
taken into account (Rentz et al., 2004). Therefore, we
consider this young mutation carrier as memory-impaired
even though he does not formally fulfil the criteria for
amnestic mild cognitive impairment by Petersen et al.
(2001). The 45-year-old-mutation carrier, on the other
hand, who is roughly 3 years separated from a probable
Alzheimer’s disease diagnosis, exhibited deficits in the
retrieval from episodic memory in both the verbal and
non-verbal domain. This subject’s WMS-R delayed memory
Fig. 4 Enhanced brain activity in the young mutation carrier. Upper panel: Displayed are activity enhancements in the young mutation carrier
versus the controls for the contrast Run 1 of associative learning versus visual baseline and the contrast associative retrieval versus visual
baseline. Lower panel: Five subjects randomly drawn from the control group (n = 21) are each compared with the remaining controls (n = 20).
Their learning- and retrieval-related brain activity was within the controls’ range.
Fig. 3 Brain activity differences between each PSEN1 C410Y mutation carrier and the controls for the contrast Run 1 of associative learning
versus visual baseline and the contrast associative retrieval versus visual baseline. Upper panel: The young mutation carrier exhibited areas of
enhanced activity. Lower panel: The middle-aged mutation carrier exhibited areas of reduced activity.
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index fell below M 1.5 SD of test norms and therefore
fulfilled the criteria for amnestic mild cognitive impairment
by Petersen et al. (2001). The other three family members,
two subjects 20 years (Y2 and Y3) and one subject of 52
years (M2) were not carrying the mutation. They served as
within-family controls. Y2’s cognitive performance was
completely normal compared with the matched controls’
and with test norms. Y3 performed at or below the matched
controls’ 7th percentile in all neuropsychological tests, but
within published test norms. M2’s performance measures
were also within test norms. Therefore, we rated these family
members cognitively intact.
Retrieval performance was more even among family
members in the associative memory-fMRI task than in the
neuropsychological examination. A likely reason for this
discrepancy might be the fact that the face–profession
combinations given for learning during fMRI had to be
learned over three learning runs and with an imagination
task that required subjects to imagine the same scene for a
given person on repeated learning runs. The latter adds a
retrieval component to the re-encoding process in Runs 2
and 3. This effective encoding procedure is probably
the reason why the two middle-aged family members
retrieved an equal amount of correct associations as their
young relatives and the young controls during the fMRI
experiment.
The fMRI results revealed that the young and the middle-
aged mutation carriers exhibited significantly altered patterns
of memory-related brain activity compared with controls
and the family members without the mutation. The young
mutation carrier exhibited an overshoot in learning- and
retrieval-related brain activity compared with controls. The
middle-aged mutation carrier, on the other hand, exhibited
very weak brain activity increases when challenged with
learning and retrieval tasks. Crucially, the enhanced brain
activity in the young mutation carrier appeared in spite of
comparable performance measures in the fMRI tasks
compared with those of the other young family members
and those of the controls. Therefore, differences in brain
activity between the young mutation carrier and the controls
cannot be attributed to differences in retrieval success
(McDermott et al., 2000; Meltzer and Constable, 2005) but
rather to the presence and the consequences of the PSEN1
mutation. In particular, the young mutation carrier
displayed enhanced brain activity in left frontal, temporal,
and parietal neocortices during learning, retrieval, and
novelty detection relative to the young controls, while the
young controls never increased their brain activity over the
young mutation carrier’s. Furthermore, activity levels in
randomly selected subjects did not clearly deviate from the
controls’ suggesting that the enhancement of learning- and
retrieval-related activity in the young mutation carrier does
not correspond to normal inter-subject variability but might
be related to the PSEN1 mutation. We focused our fMRI
analysis on the MTL because neurofibrillary tangle forma-
tion in the course of Alzheimer’s disease can usually be first
detected in the entorhinal-hippocampal area (Braak and
Braak, 1996). Indeed, the young mutation carrier exhibited
increased levels of left hippocampal activity relative to
controls during the face–profession learning task as a result
of both the whole-brain SPM analysis and the hippocampal
ROI analysis performed on the non-normalized fMRI
images. This activity overshoot might reflect additional
cognitive work to accomplish the same task and, at the
neural level, a compensatory recruitment of well functioning
neural populations to balance dysfunction in neural
populations already affected by Alzheimer’s disease-related
neuropathology. Such compensatory activity increases
during learning and retrieval have been found in the MTL
and neocortex of presymptomatic individuals at risk for
SAD due to the presence of the APOE4 allele (Bookheimer
et al., 2000; Bondi et al., 2005) and in individuals with mild
cognitive impairment (Dickerson et al., 2004; Rosano et al.,
2005). The degree of activity enhancement in these
individuals was predictive of further cognitive decline
(Bookheimer et al., 2000; Dickerson et al., 2004). Such
compensatory activity increases may be related to MTL
dysfunction secondary to the formation of neurofibrillary
tangles. The entorhinal cortex has been found affected by
intracellular neurofibrillary tangles 30–50 years prior to
Alzheimer’s disease diagnosis (Price et al., 1991; Ohm et al.,
1995; Braak and Braak, 1996; Ghebremedhin et al., 1998;
Delacourte et al., 1999). Specifically, PSEN1 mutations have
been associated with large densities of neurofibrillary tangles
in the CA regions of the hippocampus in post-mortem
brains (Sudo et al., 2005). There may be both direct effects
of the PSEN1 protein on tau phosphorylation and indirect
effects on tau pathology (Takashima et al., 1998; Boutajang-
out et al., 2002). Furthermore, PSEN1 mutations have been
associated with significant increases of plasma amyloid beta
42 levels and with a massive deposition of amyloid beta 42 in
the whole brain (Lemere et al., 1996; Iwatsubo, 1998).
Amyloid beta accumulation appears to be an early and
initiating event that triggers a series of downstream
processes including the misprocessing of the tau protein
(St George-Hyslop and Petit, 2005). Because the genetic
defect in FAD is present since birth, it is conceivable that this
cascade of Alzheimer’s disease-related neuropathological
processes takes its course already in childhood or early
adulthood. To our knowledge, there are no neuropatholo-
gical studies on children or young adults with FAD in the
literature, but studies in Down’s syndrome with Alzheimer’s
disease showed that deposition of amyloid beta 1–42 could
already be observed in the third decade of life (Teller et al.,
1996; Stoltzner et al., 2000).
The two young family members, Y2 and Y3, who were not
carrying the PSEN1mutation, exhibited a rather even pattern
of brain activity changes during learning and retrieval in the
SPM contrasts. They exhibited areas of both enhanced and
decreased learning- and retrieval-related brain activity
relative to controls. In the ROI analyses, Y2 showed one
area of lower hippocampal activity in one task and one area
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of higher hippocampal activity in another task. Since these
deviations were again bidirectional, they probably reflect
normal inter-subject variability. Also one of the five rando-
mly selected controls, which were compared to the remaining
20 controls, showed two loci of lowered hippocampal
activity. The other four randomly selected subjects ranged
within the remaining controls’ span. Y3, on the other hand,
exhibited hippocampal hypoactivation during three tasks in
the ROI analyses plus significantly lowered medial temporal
activities during two tasks in the SPM contrasts. In light of
Y3’s rather low—compared with controls, but not test
norms—memory, intelligence and executive function scores,
these data might reflect a naturally modest cognitive status
unrelated to Alzheimer’s disease.
A factor that may have contributed to the enhancement of
the fMRI signal in the young mutation carrier versus
controls is this individual’s high total IQ score of 133
(Table 1, Fig. 2, Supplementary Table S1). To assess this
possibility, we also compared the young mutation carrier
with those subjects from the control group who reached a
total IQ between 130 and 137 (n = 7). The young mutation
carrier was ranging within the p7/p93 span of these
intelligent controls with regard to all neuropsychological
variables and all behavioural variables of the fMRI tasks, but
still displayed a learning- and retrieval-related activity
enhancement within similar locations as reported for the
comparison to the whole control group (data not shown). It
should also be noted that Y2’s total IQ score was nearly as
high as the young mutation carrier’s, and Y2’s verbal
IQ score was even 10 points higher than the young mutation
carrier’s. Nevertheless, Y2 did not exhibit a learning- and
retrieval-related brain activity enhancement relative to
controls (Tables 3 and 4; Supplementary Table S3).
The middle-aged PSEN1 mutation carrier, M1, exhibited
significantly weaker MTL activity in the ROI analyses
and SPM contrasts as well as many areas of weaker
neocortical activity relative to the young controls. These
differences might not only reflect ageing but also gross
neural dysfunction associated with a more advanced stage of
Alzheimer’s disease-related neuropathology as this family
member fulfilled the criteria for amnestic mild cognitive
impairment (Petersen et al., 2001). This result is reminiscent
of observations in patients in the early stages of Alzheimer’s
disease who showed decreased task-related brain activity
levels (Small et al., 1999; Buckner et al., 2000; Kato et al.,
2001). The more aggressive nature of Alzheimer’s disease
pathology in FAD relative to SAD (Gomez-Isla et al., 1997;
Lippa et al., 2000; Sakamoto et al., 2002) might have led to
this pattern of results in our case at age 45. The other
middle-aged family member, M2, who was not carrying the
mutation, exhibited also reduced learning- and retrieval-
related MTL activity in the ROI analyses and SPM contrasts
as well as few regions of neocortical activity alterations when
compared with the young controls. Unfortunately, a middle-
aged control group is missing in this study, which limits
the interpretation of the two middle-aged individuals’ data,
because ageing is known to both increase and decrease
learning- and retrieval-related brain activity, even when
behavioural performance is matched across age groups
(e.g. Daselaar et al., 2003, 2006; Maguire and Frith, 2003;
Buckner, 2004; Cabeza et al., 2004; Hedden and Gabrieli,
2004). We assume that M2’s activity alterations are
attributable to the process of normal ageing, because they
were restricted to few brain areas and focused on the MTL,
particularly the hippocampus (whole-brain contrasts, ROI
analyses). Altered hippocampal activity in healthy older
subjects is a common finding in memory studies of normal
ageing and most probably relate to an encoding deficit
(Daselaar et al., 2003, 2006; Maguire and Frith, 2003; Cabeza
et al., 2004). Interestingly, M2 showed no hippocampal
differences to the controls during face encoding and face
recognition, which are tasks that do not rely as much on
hippocampal processing as relational memory tasks (Henke
et al., 1997). Daselaar and colleagues (2006) reported that
recollection-related hippocampal activity was reduced by
ageing, while familiarity-related rhinal cortex activity was
increased by ageing suggesting that older persons compen-
sate for their recollection deficits (associated with hippo-
campal dysfunction) by relying more on familiarity
judgements (associated with rhinal cortex functions). In
line with these results, M2 showed a remember (recollection)
score as low as M1’s, but achieved a much better know
(familiarity) score than M1 (Table 2) in the face recognition
task given during fMRI. Our fMRI block design and the
small number of trials did not allow for a separate analysis of
recollection and familiarity responses. But M2’s remember/
know dissociation, the normal neuropsychology scores
(relative to test norms), and the relatively focal alterations
in brain activity speak in favour of normal, rather than
pathological, processes of ageing.
It should be noted that the manual measurements of the
hippocampus and parahippocampal gyrus revealed compar-
able volumes between family members and the sex-matched
controls suggesting that neither the young nor the middle-
aged family members were suffering defined atrophy in the
MTL. Thus, partial volume effects due to MTL atrophy
cannot account for our imaging results. We would also like
to point out that there might be subject differences with
respect to the visual baseline condition with which we
compared the learning and retrieval conditions. These might
have added to the activity differences observed between
family members and controls.
The hyperactivation in the young mutation carrier and
the hypoactivation in the middle-aged mutation carrier
found during episodic memory tasks did not generalize to
working memory. Actually, all family members—irrespective
of genotype—displayed enhanced working memory-related
frontal and parietal activity relative to controls. This result
suggests that episodic memory tasks must be used to
provoke brain activity alterations which are indicative of
preclinical phases of Alzheimer’s disease—a result which is
in line with previous evidence (Bookheimer et al., 2000;
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Burggren et al., 2000). We can only speculate about the
origin of the increased working memory-related signal in
frontal-parietal circuits observed in the five family members.
Behaviourally, M2 scored at the low end of the young
controls’ range in the working-memory task, while M1 and
the young family members scored comparable to controls.
Each family member’s mean reaction latencies for correct
and for false answers in the working-memory task ranged
within mean 61 SD of controls. Therefore, there is no
behavioural evidence of an increased subjective task
difficulty in the young family members. Nevertheless, even
in the absence of behavioural differences, it is still possible
that the members of this particular family are more
challenged than the controls by this 2-back task, perhaps
because of less experience with this kind of cognitive
challenge or because of less favourable genetic resources, and
therefore exerted a greater cognitive effort which reflected in
a larger neural recruitment. Increased brain activity during
working-memory performance has been found within the
working-memory network independently of performance
levels within subjects with little compared to more practice
on task (Landau et al., 2004; Sayala et al., 2006), in older
compared with younger subjects (Mattay et al., 2006), and in
carriers of the less favourable polymorphisms of dopamine
regulation genes (Bertolino et al., 2006).
Our finding of amplified memory-related brain activity in
a young, asymptomatic PSEN1 mutation carrier is also in
line with the results obtained in 95 asymptomatic offspring
(50–70 years of age) of late-onset Alzheimer’s disease cases
(Bassett et al., 2006). The group statistics revealed more
intense and extensive memory-related fMRI activity in the
frontal and temporal lobes including the hippocampus in
these at-risk subjects. While it remained uncertain whether
the 95 individuals of this study will eventually be diagnosed
with Alzheimer’s disease, studies in PSEN1 mutation carriers
have the advantage of a nearly certain Alzheimer’s disease
diagnosis. Also, for the initiation of a preclinical treatment
of Alzheimer’s disease, a preclinical test ideally uncovers
first signs of Alzheimer’s disease on an individual subject
basis.
The aim of our study was to test our memory-fMRI
paradigm as a potential preclinical diagnostic tool in
cognitively intact individuals who will later manifest
Alzheimer’s disease with a high probability. Because
individuals with the PSEN1 C410Y mutation will develop
Alzheimer’s disease, they are ideal candidates for testing new
diagnostic tools. Although our imaging protocol is not
relevant for the early diagnosis of presenilin mutation
carriers, because they can be diagnosed by genotyping alone,
the present findings validate our diagnostic tool and open
the prospect of its application for the early diagnosis of
individuals from families with accumulations of sporadic
rather than autosomal dominant Alzheimer’s disease. A
limitation to our study is the inclusion of only one family
with FAD. This was due to the rarity of FAD and the
circumstance that healthy members from FAD families are
not usually inclined to undergo neuropsychological and
genetic examinations. Nevertheless, this study shows for the
first time that enhanced memory-related brain activity can
be identified on a single-subject basis decades before the
diagnosis of Alzheimer’s disease. Given the likelihood that
agents will become available that reliably delay onset and/or
slow progression of Alzheimer’s disease, it will become
essential to detect the disease early in life for best treatment
effects.
Supplementary material
Supplementary data are available at Brain Online.
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